Top 20 Companies in Animal Drug Compounding Market (2025–2035): Expert View by Spherical Insights
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
According to a research report published by Spherical Insights & Consulting, the Global Animal Drug Compounding Market Size is projected to grow from USD 1.55 Billion in 2024 to USD 3.86 Billion by 2035, at a CAGR of 8.65% during the forecast period 2024–2035. The animal drug compounding market is driven by rising pet ownership, increasing expenditure on specialized veterinary care, and the need for tailored dosages or formulations for chronic conditions in pets. It is further propelled by drug shortages, the demand for palatable, flavored medicines, and the growing prevalence of diseases requiring specialized, non-commercial treatments.
Introduction
The animal drug compounding market consists of the customized preparation, mixing, or alteration of ingredients by licensed pharmacists or veterinarians to create tailored medications for animals. Livestock Health and Disease Control (LHDC) is a centrally sponsored scheme aimed at reducing risks to animal health through prophylactic vaccination, capacity building of veterinary services, and strengthening infrastructure.
In the United States, the U.S. Food and Drug Administration regulates the compounding of animal drugs from bulk drug substances to ensure safety and appropriate use. Guidance for Industry 256 provides guidance for veterinarians and pharmacists, including provisions for compounding office stock medications when no FDA-approved, conditionally approved, or indexed drug is available. The market offers several opportunities, such as treating chronic conditions in aging pets (arthritis, diabetes), dermatology applications, and filling gaps in commercial medication availability.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Animal Drug Compounding Market.
Market Segmentation
Global Animal Drug Compounding Market Size, Share, By Animal (Companion Animals, Livestock Animals), By Dosage Form (Suspension, Solutions, Capsules & Tablets, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035
Animal Drug Compounding Market & Statistics
- The Market Size for Animal Drug Compounding Was Estimated to be worth USD 1.55 Billion in 2024.
- The Market is Going to Expand at a CAGR of 8.65% between 2025 and 2035.
- The Global Animal Drug Compounding Market Size is anticipated to reach USD 3.86 Billion by 2035.
- North America is expected to generate the largest demand during the forecast period in the Animal Drug Compounding Market.
- Asia Pacific is expected to grow the fastest during the forecast period in the Global Animal Drug Compounding Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the animal drug compounding market. In June 2025, Wedgewood Pharmacy announced the launch of a compounded oral antiviral GS-441524 formulation for treating feline infectious peritonitis (FIP). Compounded as a 50 mg/ml flavored oral oil suspension, it expands the company portfolio alongside molnupiravir, enabling veterinarians to prescribe two antiviral options through a single pharmacy source. The Veterinary Medicinal Products Regulation supports the safe use of compounded medicines in the EU, ensuring high standards. In May 2025, the SFDA introduced streamlined veterinary drug approval guidelines to support market expansion.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Animal Drug Compounding Market.
North America is expected to generate the largest demand during the forecast period in the animal drug compounding market. In January 2025, Patterson Veterinary invested in advanced robotics for pharmaceutical compounding, aiming to improve dosing precision and operational efficiency in veterinary medications. The initiative supports consistent formulation quality and scalable production, helping veterinarians access accurately compounded treatments. The FDA estimates that veterinarians in the U.S. write approximately 6.3 million prescriptions for compounded animal medications annually.
Top 10 trends in the Animal Drug Compounding Market
- Rising demand for personalized pet medicine
- Pet humanization trends
- Growth in flavored dosage forms
- Dominance of CNS agents and behavior meds
- Expansion of transdermal/topical delivery
- Rise of 503B outsourcing facilities
- Shortage mitigation and customization
- Advancements in veterinary compounding tech
- Specialized care for chronic illnesses
- Integration with telemedicine & online pharmacy
- Rising demand for personalized pet medicine
The demand for personalized pet medicine is surging, driven by the humanization of pets, where owners seek high-quality, tailored healthcare for longer, healthier pet lives.
2.Pet humanization trends
Increased pet owner’s willingness to pay for high-quality, specialty, or bespoke medications, mirroring human healthcare approaches.
3.Growth in flavored dosage forms
Compounding medicines into treats, liquids, or chews that make it easier to administer medication to cats and dogs.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Animal Drug Compounding Market.
4.Dominance of CNS agents and behavior meds
High demand for compounded drugs like gabapentin and fluoxetine for seizures and anxiety, especially for aging pets.
5.Expansion of transdermal/topical delivery
The field of transdermal and topical drug delivery is experiencing a significant expansion, driven by the need to overcome the limitations of conventional oral and intravenous methods—such as first-pass metabolism, gastrointestinal degradation, and patient discomfort.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the animal drug compounding market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Animal Drug Compounding Market.
Top 20 Companies Leading the Animal Drug Compounding Market
- Wedgewood Pharmacy
- Vimian Group AB
- Mixlab, Inc.
- Epicur Pharma
- Bova
- Grey Wolf Animal Health Corp
- Triangle Compounding Pharmacy, Inc.
- Davis Islands Pharmacy and Compounding Lab
- Custom Med Compounding Pharmacy
- Central Compounding Center South
- Wedgewood Pharmacy
Headquarters: Swedesboro, New Jersey, United States
Wedgewood Pharmacy is one of the leading veterinary compounding pharmacies in the United States specializing in customized medications for animals. The company provides compounded pharmaceuticals for companion animals, equine, and exotic species, offering dosage forms such as flavored suspensions, capsules, chewable tablets, and transdermal gels designed to improve medication compliance. Wedgewood supplies veterinary hospitals, clinics, and pet owners with tailored formulations and operates FDA-registered facilities that follow strict pharmaceutical quality standards. The company employs approximately 1,000+ people and generates an estimated USD 200-600 million in annual revenue (2025 estimate). Wedgewood primarily operates across the United States, with distribution networks serving veterinary customers nationwide and limited international reach. Major market participants competing with the company in the veterinary compounding space include Fagron, Medisca, Triangle Compounding Pharmacy, Diamondback Drugs, and Stokes Pharmacy.
2.Vimian Group AB
Headquarters: Stockholm, Sweden
Vimian Group AB is a global animal health company focused on developing and distributing specialized veterinary products and services for companion animals. Founded in 2021, the company operates through multiple business segments, including specialty pharmaceuticals, veterinary diagnostics, medical technology, and veterinary services. Vimian has expanded rapidly through strategic acquisitions, building a portfolio of veterinary healthcare companies serving clinics and veterinary professionals worldwide. The company employs more than 1,000 people globally and reported approximately EUR 374.8 million (about USD 400 million) in revenue in 2024, with continued growth expected through 2025. Vimian operates in over 20 countries across Europe, North America, and Asia-Pacific, supplying products and services to veterinary clinics and animal healthcare providers.
3.Mixlab Inc.
Headquarters: New York, New York, United State
Mixlab, Inc. is a technology-enabled veterinary compounding pharmacy that focuses on personalized medications and convenient home delivery services for pets. Founded in 2017, the company integrates digital pharmacy solutions with veterinary healthcare to streamline prescription management for veterinarians and pet owners. Mixlab specializes in customized dosage forms, including flavored oral liquids, chewable tablets, and topical formulations designed to improve medication adherence in animals. The company employs approximately 150-200 people and generates an estimated USD 20-40 million in annual revenue as of 2025. Mixlab primarily operates in the United States, partnering with veterinary clinics and hospitals to provide fast compounding and delivery services
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Animal Drug Compounding Market.
4.Epicur Pharma
Headquarters: Mount Laurel, New Jersey, United States
Epicur Pharma is a veterinary pharmaceutical company and a subsidiary of Stokes Healthcare that focuses on manufacturing high-quality animal medications through an FDA-registered 503B outsourcing facility. The company produces standardized, non-patient-specific veterinary drugs designed to support veterinarians in delivering consistent and reliable treatments for animals. Epicur Pharma supplies a range of medications used in treating chronic conditions in companion animals, including endocrine and dermatological disorders. The company employs an estimated 200+ people and generates approximately USD 50-100 million in annual revenue (2025 estimate). Epicur primarily serves the United States veterinary pharmaceutical market, supplying veterinary hospitals and clinics nationwide
5.Bova
Headquarters: London, United Kingdom
Bova is a veterinary compounding pharmaceutical company specializing in customized medications for animals when commercially licensed treatments are unavailable or unsuitable. Founded in 2012, the company develops tailored formulations including oral liquids, capsules, and topical medications designed for companion animals and exotic species. Bova works closely with veterinarians to create patient-specific treatments and has gained recognition for developing innovative therapies for rare veterinary conditions. The company employs approximately 150+ people and generates an estimated USD 30-60 million in annual revenue as of 2025. Bova operates primarily in the United Kingdom and Australia, with an expanding presence in parts of Europe through veterinary partnerships.
Are you ready to discover more about the animal drug compounding market?
The report provides an in-depth analysis of the leading companies operating in the global animal drug compounding market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Animal Drug Compounding Market.
Company Profiles
- Wedgewood Pharmacy
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Vimian Group AB
- Mixlab, Inc.
- Epicur Pharma
- Bova
- Grey Wolf Animal Health Corp
- Triangle Compounding Pharmacy, Inc.
- Davis Islands Pharmacy and Compounding Lab
- Custom Med Compounding Pharmacy
- Central Compounding Center South
- Wellness Pharmacy of Cary
- Millers Pharmacy & Compounding Center
- Pharmaca Integrative Pharmacy, Inc.
- Akina, Inc.
- Caringbah Compounding Pharmacy
- Smiths Compounding Pharmacy
- Specialist Compounding Pharmacy Pte Ltd
- Tache Pharmacy
- Hoyes Pharmacy
- Vertisis Custom Pharmacy
- Others
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Animal Drug Compounding Market.
Conclusion
The animal drug compounding market is expected to witness steady expansion, driven by increasing pet ownership, the growing humanization of pets, and rising demand for personalized veterinary medicine. Compounded drugs help address dosage customization, palatability challenges, and shortages of commercially available medications. Regulatory frameworks such as the U.S. Food and Drug Administration guidance for industry 256 and the EU veterinary medicinal products regulation are supporting safe and standardized compounding practices. Advancements in compounding technologies, expanding 503B outsourcing facilities, and supportive regulatory frameworks are further strengthening market development. North America currently dominates the market due to a well-established veterinary healthcare infrastructure, while Asia-Pacific is expected to witness the fastest growth during the forecast period. Leading companies are focusing on innovation, strategic partnerships, and product diversification to strengthen their market presence. Overall, the sector presents significant opportunities for veterinary pharmaceutical providers worldwide.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?